The story has been updated to include comments from Danaher's third quarter conference call this morning.

NEW YORK (GenomeWeb) – Danaher today reported 4 percent year-over-year growth in its third quarter revenues as the firm just missed the average analyst estimate on the top line but beat it on the bottom line.

For the three months ended Sept. 26, the Washington-based conglomerate posted $4.87 billion in revenues, up from $4.67 billion during the third quarter of 2013. The consensus Wall Street estimate was $4.90 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.